All Work

Vandita Jadeja

Prediction: AbbVie Will End The Year at This Price

AbbVie's blockbuster drugs are surging while a major acquisition looms, but a trailing P/E of 71 and one model pricing the stock nearly $50 below current levels raises a real question about whether the…

Vandita Jadeja · 1 month ago

Price Prediction: Credo Will Trade at This Price in 2030

Credo Technology tripled revenue and crushed earnings, yet the stock sits 10% below its highs while analysts debate whether a specific price target by 2030 is ambition or fantasy. Three things have to break…

Vandita Jadeja · 1 month ago

Target Stock at 52-Week High: Buy, Sell or Hold?

Target has surged 50% this year on the back of one standout quarter, but the analyst consensus now sits below the stock price and the consumer backdrop looks shakier by the month. Before you…

Vandita Jadeja · 1 month ago

These 3 Chip Stocks Could Be Entering a New Growth Cycle

AMD, Micron, and Marvell have already posted triple-digit gains in 2026, but a summer pullback is raising a bigger question: whether the AI infrastructure wave has enough fuel left to push all three to…

Vandita Jadeja · 1 month ago

Down 50% in The Year, Is SMCI a Buy?

Super Micro Computer has shed half its value in a year, and now a board investigation, a $6.6 billion cash outflow, and a potential 48% upside are all pointing in different directions at once.

Vandita Jadeja · 1 month ago

1 Reason Wall Street Is Obsessed With This Tech Stock

Marvell Technology just dropped nearly 21% in a month, and one analyst with skin in the game is treating that selloff as a buying opportunity. The reason comes down to a single business segment…

Vandita Jadeja · 1 month ago

Prediction: Where Will Webull Stock Be in 5 Years?

Webull just posted 104% volume growth while its stock sits 45% below where it started the year, and a handful of catalysts could either close that gap dramatically or prove the skeptics right.

Vandita Jadeja · 1 month ago

AI Darling on the Hot Seat: Will Palantir Deliver?

Palantir posted blowout earnings while its stock cratered 30% this year, creating a tension that forces a hard question about whether the market is punishing a compounding machine or finally pricing in a valuation…

Vandita Jadeja · 1 month ago